Test Price
2,800 AED✅ Home Collection Available
MYH9 Gene (Epstein Syndrome) Genetic Test in UAE | 2800 AED | DHA Certified Molecular Analysis
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytic sensitivity via ISO 9001:2015 certified NGS methodology (INT/EGQ/2509DA/3139).
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all UAE emirates.
- Clinical Guidance: Post-test telephone consultation with a board-certified medical geneticist for result interpretation per DHA guidelines.
- Insurance Support: Direct verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced next-generation sequencing (NGS) test analyzes the entire MYH9 gene to detect pathogenic variants causing Epstein syndrome and related MYH9 disorders, providing definitive molecular diagnosis for thrombocytopenia, sensorineural hearing loss, cataracts, and progressive nephritis.
| Feature | Our Test (NGS – UAE Certified) | Closest Alternative (Limited-Panel PCR) |
|---|---|---|
| Diagnostic Precision | 99.9% analytic sensitivity, full gene coverage | ~85% sensitivity, hotspot mutations only |
| Methodology | Next-Generation Sequencing (NGS) with MLPA backup | Sanger sequencing of selected exons |
| Turnaround Time (TAT) | 3–4 Weeks | 4–6 Weeks |
| Sample Type | Whole Blood, Extracted DNA, or FTA Card | Whole Blood only |
| Price | 2800 AED | Varies (often >3200 AED) |
Physician Insight & Safety Protocols
"In my practice, I emphasise that MYH9 gene sequencing offers high diagnostic certainty, but clinical heterogeneity means results must be correlated with haematologic, audiologic, and renal assessments. A normal result does not exclude inherited thrombocytopenias, and pathogenic variants require multidisciplinary management."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notes for Patients
Do not discontinue any prescribed medications (e.g., eltrombopag, corticosteroids) without consulting your physician. These agents may influence platelet counts and require careful monitoring. This test does not replace clinical evaluation for acute bleeding.
Exclusion Criteria & Urgent Red Flags
- Minors: Written consent from legal guardian is mandatory under UAE Federal Decree-Law No. 4 of 2016 on Medical Liability. Testing on minors without guardian consent is strictly prohibited.
- Active Bleeding Diathesis: Patients with spontaneous bleeding or severe thrombocytopenia (<10×10⁹/L) require medical stabilisation before venipuncture.
- Recent Allogeneic Transplant: Bone marrow transplant recipients within 6 months may have chimeric DNA; alternative sampling or delayed testing is advised.
- Pregnancy: Testing of pregnant women requires genetic counselling regarding fetal implications; non-invasive alternatives should be discussed.
Seek Emergency Care If You Experience:
- Sudden petechiae or severe bruising
- Spontaneous bleeding from gums, nose, or GI tract
- Acute visual changes or sudden hearing loss
- Signs of acute renal failure: reduced urine output, oedema, severe fatigue
Patient FAQ & Clinical Guidance
1. What exactly does the MYH9 gene test diagnose?
Direct Answer: This test sequences the entire MYH9 gene to detect pathogenic variants causing Epstein syndrome and related inherited thrombocytopenias, sensorineural hearing loss, cataracts, and progressive kidney disease. It provides a definitive molecular diagnosis for these conditions.
2. How is the sample collected and can I arrange home collection?
Direct Answer: A trained phlebotomist collects a small blood sample via standard venipuncture. We also offer ISO-certified cold-chain home collection across all UAE emirates, available daily from 8 AM to 11 PM. You can schedule via WhatsApp +971 54 548 8731.
3. Why does the report take 3–4 weeks and how will I receive the results?
Direct Answer: The turnaround time incorporates DNA extraction, NGS library preparation, sequencing, bioinformatics analysis, and expert clinical interpretation to ensure 99.9% accuracy. Results are delivered electronically via secure portal and follow-up telephone consultation with a medical geneticist.
4. Is this test covered by insurance?
Direct Answer: Coverage varies by provider. Our team can verify your insurance eligibility directly via WhatsApp +971 54 548 8731. Please have your policy details ready for a rapid assessment.
UAE Regulatory & Data Privacy Adherence
Compliance Framework: This test is performed in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 certification (INT/EGQ/2509DA/3139) guarantees rigorous quality management. For insurance verification, contact WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | MYH9 Gene (Epstein Syndrome) NGS Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with MLPA backup |
| ICD-10-CM Code | D69.1 (Qualitative platelet defects), D72.8 (Leukocyte disorders), H90.5 (Hearing loss) |
| LOINC Code | 90231-5 (MYH9 gene full sequencing) |
| DHA Facility License & Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians